VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 43 filers reported holding VBI VACCINES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,460,000 | +16.9% | 1,850,000 | 0.0% | 0.12% | -9.2% |
| Q4 2018 | $2,960,000 | -33.9% | 1,850,000 | 0.0% | 0.13% | -20.1% |
| Q3 2018 | $4,477,000 | -12.0% | 1,850,000 | 0.0% | 0.16% | -22.3% |
| Q2 2018 | $5,088,000 | -21.4% | 1,850,000 | 0.0% | 0.21% | -30.4% |
| Q1 2018 | $6,475,000 | -18.0% | 1,850,000 | 0.0% | 0.30% | -26.5% |
| Q4 2017 | $7,900,000 | – | 1,850,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |